Logo Image
|Videos|October 5, 2020

Botulinum toxin benefits patients with adult neurogenic lower urinary tract dysfunction

R. Corey O'Connor, MD, discusses findings from a recent study published in Neurourology and Urodynamics.

In this interview, R. Corey O'Connor, MD, discusses the recent Neurourology and Urodynamics paper, “Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction," for which he served as a study author. O'Connor is associate professor of urology at the Medical College of Wisconsin, Milwaukee.

More videos:

How do OAB patient education materials measure up?​

Disposable ureteroscope reduces costs of care​

Gender disparity seen with renal cell carcinoma management​

Related Content

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies
Multimedia

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

View more
Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis
Video

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

View more